Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Phcog.Net JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS Volume 6 · Issue 3 2015 · pp. 123–193
    Search this issue

    Cover: Journal of Pharmacology and Pharmacotherapeutics

    Journal of Pharmacology and Pharmacotherapeutics

    Volume 6, Issue 3

    2015 · pp. 123–193 · 17 articles

    Volume
    6
    Issue
    3
    Published
    2015
    Pages
    123–193
    Articles
    17
    Sections
    9
    ISSN
    ISSN: Print - 0976-500X, Online - 0976-5018
    Journal
    J Pharmacol. Pharmacother.

    In this issue

    Editorial

    1. Forum Article

      Are we moving towards a new definition of essential medicines?

      Manikandan S

      pp. 123–5 · DOI: 10.4103/0976-500X.162008 · Published 2015

      Essential medicines are defined as “those that satisfy the priority health care needs of the population,” with the concept being that they are intended to be available within the context of a functioning healthcare syste

    Review Article

    1. Review

      Inhaled insulin: A “puff” than a “shot” before meals

      Dick B. S. Brashier, Anjan Khadka, Tejus Anantharamu, Ashok Kumar Sharma, A. K. Gupta

      pp. 126–129 · DOI: 10.4103/0976-500X.162013 · Published 2015

      Diabetes is a metabolic disorder characterized by relative or absolute deficiency of insulin, resulting in hyperglycemia. The main treatment of diabetes relies on subcutaneous insulin administration by injection or conti

    Research Paper

    1. Article

      Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome

      Sushant Khurana, Surabhi Gupta, HiraLal Bhalla, Shefali Nandwani, Varad Gupta

      pp. 130–135 · DOI: 10.4103/0976-500X.162011 · Published 2015

      Objectives: To compare anti‑inflammatory effect of atorvastatin and rosuvastatin in patients of acute coronary syndrome. Materials and Methods: The study was a prospective, open‑labeled, randomized and single‑center stud

    2. Article

      Inhibition by sildenafil of contractility of isolated non‑pregnant human myometrium

      Aruldhas Blessed Winston, Kaysina Vazhudhi, Sumalya Sen, Elsy Thomas, Santhosh Benjamin

      pp. 136–141 · DOI: 10.4103/0976-500X.162020 · Published 2015

      Objective: To investigate the ability of sildenafil to inhibit the contractility of isolated non pregnant human myometrium. Materials and Methods: The inhibitory effect of three concentrations (3, 10, and 30 µM) of silde

    3. Article

      Effectiveness of vitamin D3 in severe persistent asthmatic patients: A double blind, randomized, clinical study

      Muhasaparur Ganesan Rajanandh, Arcot D. Nageswari, Giridharan Prathiksha

      pp. 142–146 · DOI: 10.4103/0976-500X.162022 · Published 2015

      Objective: To assess the pulmonary function and quality of life in asthma patients receiving vitamin D3 supplementation with inhaled budesonide and formoterol. Materials and Methods: This was a double blinded, randomized

    4. Article

      The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy

      Leena Patel, Aswin Thaker

      pp. 147–148 · DOI: 10.4103/0976-500X.162014 · Published 2015

      Introduction: To investigate the actions of adenosine A2B receptor modulators on VEGF and NO levels in CsA nephropathy. Materials and Methods: Nephropathy was induced by administrating 25 mg/kg (s.c) of CsA for 5 weeks.

    Research Letter

    1. Article

      Identification and characterization of primate P-glycoprotein

      Mesfin Yimam

      pp. 154–6 · DOI: 10.4103/0976-500X.162021 · Published 2015

      Achieving the therapeutic goal of human immunodeficiency virus(HIV) infection is complex in nature due to the potential drug–drug interactions, modulations in the cytochrome P450 enzyme and/or drug transporters such as P

    Case Report

    1. Article

      Double trouble: Cyclosporine‑induced thrombocytosis in a patient with methotrexate toxicity: Are they related?

      Cherukuri Tejaswi, Saritha Mohanan, Rangaraj Murugaiyan, Kaliaperumal Karthikeyan

      pp. 160–162 · DOI: 10.4103/0976-500X.162005 · Published 2015

      Psoriasis is a common, chronic, disfiguring, inflammatory, and proliferative condition of the skin. It manifests with varying degrees of severity and can be treated with various immune modulators. This is a case report o

    2. Article

      Exercise‑induced anaphylaxis and antileukotriene montelukast

      Sapna Gajbhiye, Rajendra Prasad Agrawal, Shubham Atal, Vikalp Tiwari, Pradeep Phadnis

      pp. 163–165 · DOI: 10.4103/0976-500X.162007 · Published 2015

      We report a rare case of exercise‑induced anaphylaxis (EIA), occurring exclusively with exercise, without any other associated trigger, detected in the prodromal phase, and prevented from additional anaphylaxis episodes

    3. Article

      Intestinal pseudo‑obstruction following oral baclofen: An unusual complication

      Vilvapathy Senguttuvan Karthikeyan, Kuppusamy Senthilkumaran, Bettaiyagowder Easwaran, Rajamariappan Rajbhaskar

      pp. 169–171 · DOI: 10.4103/0976-500X.162010 · Published 2015

      Baclofen is a gamma- aminobutyric acid B (GABA B) agonist used for the management of spasticity associated with spinal cord injury. Oral baclofen might cause constipation, but intestinal pseudo‑obstruction is very rare.

    4. Article

      Acalculous pyelonephritis and cholecystitis occurring simultaneously in a diabetic patient on sitagliptin therapy

      Jayaprakash Sahoo, Sadishkumar Kamalanathan, Muthupillai Vivekanandan, Rathinam Palamalai Swaminathan

      pp. 172–174 · DOI: 10.4103/0976-500X.162016 · Published 2015

      Dipeptidyl peptidase‑4 (DPP‑4) inhibitors are a new class of anti‑diabetic drugs. They control both fasting and postprandial hyperglycemia by inhibiting degradation of incretin hormones, such as, glucagon‑like peptide‑1(

    5. Article

      Complete resistance after maximal dose of rocuronium

      Annalisa Capuano, Maria Giuseppa Sullo, Concetta Rafaniello, Liberata Sportiello, Pierfrancesco Fusco, Macella De Vizia, Fausto Ferraro

      pp. 175–178 · DOI: 10.4103/0976-500X.162012 · Published 2015

      Rocuronium is a non‑depolarizing neuromuscular blocking agent (NDNMBA), employed in the clinic as an adjunct to general anesthesia to facilitate tracheal intubation rapid sequence, and to provide skeletal muscle relaxati

    6. Article

      Life‑threatening bradyarrhythmia with oral phenytoin overdose

      Giridharan Srinivasan, Mukta Wyawahare, Pratheesh George Mathen, Dharanipragada K.

      pp. 179–181 · DOI: 10.4103/0976-500X.162017 · Published 2015

      We report a case of a 41‑year‑old lady, who developed severe hypotension and sinus bradycardia, following oral consumption of 20 g of phenytoin and 500 mg of glibenclamide. She required high dose of inotropes and a tempo

    Correspondence

    1. Article

      Authors' reply

      Jayanthi Mathaiyan, Tanvi Jain, Biswajit Dubashi, K. Satyanarayana Reddy, Gitanjali Batmanabane

      pp. 182–183 · DOI: 10.4103/0976-500X.162053 · Published 2015

    Webwise

    1. Article

      International conference on harmonization of technical requirements for registration of pharmaceuticals for human use

      Jatinder Singh

      pp. 185–187 · DOI: 10.4103/0976-500X.162004 · Published 2015

    1. Article

      Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation

      Tejus Anantharamu, Sushil Sharma, Ajay Kumar Gupta, Navdeep Dahiya, Dick B. Singh Brashier

      pp. 188–192 · DOI: 10.4103/0976-500X.162015 · Published 2015

      Opioid‑induced constipation (OIC) is one of the most troublesome and the most common effects of opioid use leading to deterioration in quality of life of the patients and also has potentially deleterious repercussions on

    Erratum

    1. Article

      Stevens-Johnson syndrome caused by Cefepime: Erratum

      pp. 193–193 · DOI: 10.4103/0976-500X.162023 · Published 2015